Profiel
Kaushik J.
Dave served as President, CEO, CFO, Secretary & Director at Actinium Pharmaceuticals, Inc. from 2013 to 2017.
Prior to that, he was the Executive Vice President-Product Development at Antares Pharma, Inc. from 2008 to 2013 and Vice President-Product Development at Palatin Technologies, Inc. from 2001 to 2006.
He also worked as an Executive Director-Clinical & Regulatory Affairs at Insmed Ltd.
Dr. Dave received his undergraduate degree from the University of Bath, his doctorate from the University of Kansas, and his MBA from The Wharton School of the University of Pennsylvania.
Eerdere bekende functies van Kaushik J. Dave
| Bedrijven | Functie | Einde |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Chief Executive Officer | 12-05-2017 |
| ANTARES PHARMA, INC. | Chief Tech/Sci/R&D Officer | 17-06-2011 |
| PALATIN TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Insmed Ltd.
 Insmed Ltd. Pharmaceuticals: MajorHealth Technology Insmed Ltd. develops and manufactures pharmaceutical products for the treatment of lung diseases. Its products are used for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. The company is located in London, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Kaushik J. Dave
| University of Bath | Undergraduate Degree |
| University of Kansas | Doctorate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PALATIN TECHNOLOGIES, INC. | Health Technology |
| ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Insmed Ltd.
Insmed Ltd. Pharmaceuticals: MajorHealth Technology Insmed Ltd. develops and manufactures pharmaceutical products for the treatment of lung diseases. Its products are used for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. The company is located in London, the United Kingdom. | Health Technology |
